Loading…

Co-ordinate expression of alpha5 beta1 integrin and fibronectin in Dupuytren's disease

The expression of alpha5 beta1 (α5 β1): integrin and its extracellular ligand fibronectin was studied immunohistochemically in 23 cases of Dupuytren's disease using an immunoperoxidase method for light microscopic visualization. All cases consisted of multiple nodules showing a variable degree...

Full description

Saved in:
Bibliographic Details
Published in:Acta histochemica 1995, Vol.97 (3), p.229-233
Main Authors: Magro, Gaetano, Lanzafame, Salvatore, Micali, Giovanni
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The expression of alpha5 beta1 (α5 β1): integrin and its extracellular ligand fibronectin was studied immunohistochemically in 23 cases of Dupuytren's disease using an immunoperoxidase method for light microscopic visualization. All cases consisted of multiple nodules showing a variable degree of cellularity and fibrosis. Depending on the histological appearance of these nodules, each case was assigned to the three following phases: proliferative, involutional and residual. Alpha5 beta 1 integrin was detected in the highly cellular areas of both proliferative and involutional phases where fibronectin was simultaneously expressed in the extracellular matrix (ECM). Diversely α5 β1 and fibronectin disappeared from the hypocellular areas of involutional phase, undergoing fibrotic transformation, from the fibrotic connective tissue of residual phases. These findings indicate that the expression pattern of α5 β1 integrin correlates with the presence in the ECM of the corresponding ligand fibronectin during the different phases of Dupuytren's disease. We suggest that α5 β1 integrin, linking fibronectin to stromal cells of both proliferative and involutional phases, may be involved in the contractile processes occuring in Dupuytren's disease.
ISSN:0065-1281
1618-0372
DOI:10.1016/S0065-1281(11)80184-4